Amphastar Pharmaceuticals, Inc.
AMPH
$27.10
-$0.48-1.74%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -57.09% | -18.23% | -41.44% | 4.97% | -17.86% |
| Total Depreciation and Amortization | 9.25% | 14.80% | 8.91% | 6.35% | 6.35% |
| Total Amortization of Deferred Charges | 18.95% | -65.44% | -64.19% | -75.15% | -85.79% |
| Total Other Non-Cash Items | -43.65% | 1.04% | 220.47% | -596.37% | 470.46% |
| Change in Net Operating Assets | 263.74% | -314.53% | -130.06% | 67.88% | -27.56% |
| Cash from Operations | -12.31% | -48.50% | -36.56% | 21.62% | -6.80% |
| Capital Expenditure | 61.23% | -74.80% | -21.65% | -31.44% | -35.32% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | 100.00% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 31.37% | -84.74% | -11.87% | 75.14% | -35.18% |
| Cash from Investing | 43.27% | 99.11% | -31.21% | 65.38% | -11.02% |
| Total Debt Issued | -98.19% | 16,616.00% | -59.77% | -- | -97.24% |
| Total Debt Repaid | -7.32% | 99.54% | 61.22% | 99.77% | 99.98% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | 84.70% | -1,187.18% | 9.39% | -- | 36.61% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 99.32% | -25,400.00% | -67.46% | 104.48% | 94.38% |
| Cash from Financing | 80.95% | -181.84% | -6.80% | 28.12% | -126.34% |
| Foreign Exchange rate Adjustments | 34.92% | 847.37% | 221.65% | 95.38% | -65.79% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1,044.41% | 142.56% | -45.17% | 67.98% | -97.91% |